Thiamphenicol

규격

15318-45-3CAS 번호

239-355-3EC 번호

2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamideIUPAC 명칭

C12H15Cl2NO5S화학식

356.2 g/mol분자량

thiamphenicol; 15318-45-3; Thiophenicol; Thiocymetin; Dextrosulphenidol; (+)-Thiamphenicol; Thiamphenicolum; Tiamfenicol; Tiamfenicolo; Armai; WIN-5063-2; Urfamycine; Igralin; Neomyson; Descocin; Macphenicol; Masatirin; Urfamicina; Efnicol; Hyrazin; Rincrol; tianfenicol; DTXSID5021338; FLQ7571NPM; Methylsulfonylchloramphenicol; CCRIS 8588; 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide; NSC-522822; 2,2-dichloro-N-{(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-[4-(methylsulfonyl)phenyl]ethyl}acetamide; DTXCID801338; CHEBI:32215; Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-(methylsulfonyl)phenyl)ethyl)-, (R-(R*,R*))-; 2,2-Dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-[4-(methylsulfonyl)phenyl]ethyl]acetamide; Dextrosulfenidol; 2,2-DICHLORO-N-((1R,2R)-2-HYDROXY-1-(HYDROXYMETHYL)-2-(4-(METHYLSULFONYL)PHENYL)ETHYL)ACETAMIDE; 2,2-dichloro-N-((1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl)acetamide; RefChem:389313; J01BA02; CB-8053; (alphaR,betaR)-2,2-Dichloro-N-(beta-hydroxy-alpha-hydroxymethyl-4-methylsulphonylphenethyl)acetamide; 239-355-3; Thiocymetin (TN); Armai (TN); Dexawin; Racephenicol [USAN]; Thiamphenicol (Thiophenicol); MFCD00467983; Racefenicol [INN]; C12H15Cl2NO5S; 2,2-dichloro-N-((1R,2R)-1,3-dihydroxy-1-(4-(methylsulfonyl)phenyl)propan-2-yl)acetamide; WIN 5063-2; MLS001332640; D-(+)-threo-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide; Acetamide,2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-[4-(methylsulfonyl)phenyl]ethyl]-; SMR000857096; D-Thiocymetin; D-Thiophenicol; Acetamide, 2,2-dichloro-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-(methylsulfonyl)phenyl)ethyl)-; Tiamfenicolo [DCIT]; Thiamphenicol dl-form; Tiamfenicol [INN-Spanish]; Thiamphenicolum [INN-Latin]; 8065 C.B.; Racefenicolo [DCIT]; SR-05000001829; Thiophenicol;Dextrosulphenidol; EINECS 239-355-3; Thiamphenicol [USAN:INN:BAN:JAN]; UNII-FLQ7571NPM; NSC 522822; Racefenicolum [INN-Latin]; Thiophenicol;; Thiocymetin;; Propacin;; Dextrosulfenidol;; Thiamphenicol CRS; UNII-283383NO13; NCGC00016714-01; Prestwick_885; CAS-15318-45-3; (+/-)-Thiamphenicol; Spectrum_001428; Thiamphenicol (Standard); Prestwick0_000025; Prestwick1_000025; Prestwick2_000025; Prestwick3_000025; Spectrum2_000856; Spectrum3_001562; Spectrum4_000733; Spectrum5_001617; THIAMPHENICOL [MI]; D-d-threo-2-Dichloroacetamido-1-(4-methylsulfonylphenyl)-1,3-propanediol; D-threo-(1R,2R)-1-(p-Methylsulfonylphenyl)-2-dichloroacetamido-1,3-propanediol; THIAMPHENICOL [INN]; THIAMPHENICOL [JAN]; THIAMPHENICOL [USAN]; SCHEMBL34635; BSPBio_000089; BSPBio_003064; KBioGR_001026; KBioSS_001908; cid_27200; MLS001332639; MLS002154177; DivK1c_000842; SPECTRUM1503136; THIAMPHENICOL [MART.]; SPBio_000871; SPBio_002010; THIAMPHENICOL [WHO-DD]; BPBio1_000099; orb1226141; orb1308224; orb3140181; CHEMBL1236282; Thiamphenicol (JAN/USAN/INN); BDBM58925; GTPL12400; HMS502K04; HY-B0479R; KBio1_000842; KBio2_001908; KBio2_004476; KBio2_007044; KBio3_002564; MSK7002; NINDS_000842; Thiamphenicol, analytical standard; HMS1568E11; HMS1922G19; HMS2092L18; HMS2095E11; HMS2232E21; HMS3712E11; Pharmakon1600-01503136; THIAMPHENICOL DL-FORM [MI]; HY-B0479; THIAMPHENICOL [EP MONOGRAPH]; Tox21_110577; Tox21_200816; CCG-40309; MSK7002-100M; NSC758396; AKOS015951269; dl-threo-2-Dichloroacetamido-1-(4-methylsulfonyl-phenyl)-1,3-propanediol; MSK7002-1000M; Tox21_110577_1; DB08621; NSC-758396; 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methanesulfonylphenyl)propan-2-yl]acetamide; IDI1_000842; SMP2_000125; NCGC00178319-01; NCGC00178319-02; NCGC00178319-03; NCGC00178319-06; NCGC00178319-07; NCGC00258370-01; (+-)-threo-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide; Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)-, D-threo-(+); Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)-, threo-(+-)-; AS-12501; SY073192; SBI-0051779.P002; NS00098623; SW197006-3; Thiamphenicol 1000 microg/mL in Acetonitrile; Thiamphenicol Solution in Methanol, 100ug/mL; D01407; Thiamphenicol Solution in Methanol, 1000ug/mL; AB00052321_10; AB00052321_11; F510285; Q425015; SR-05000001829-1; SR-05000001829-3; BRD-K79711234-001-06-8; BRD-K79711234-001-11-8; BRD-K79711234-001-17-5; BRD-K79711234-001-18-3; Thiamphenicol, European Pharmacopoeia (EP) Reference Standard; 2,2-Dichloro-N-[(1R,2R)-1,3-dihydroxy-1-[4-(methylsulfonyl)phenyl]-2-propyl]acetamide; 2,2-dichloro-N-[(1R,2R)-2-hydroxy-2-(4-mesylphenyl)-1-methylol-ethyl]acetamide; 2,2-Dichloro-N-{(1R,2R)-1,3-dihydroxy-1-[4-(methanesulfonyl)phenyl]propan-2-yl}acetamide; 2,2-bis(chloranyl)-N-[(1R,2R)-1-(4-methylsulfonylphenyl)-1,3-bis(oxidanyl)propan-2-yl]ethanamide; 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-methylsulfonylphenyl)ethyl]acetamide; Acetamide, 2,2-dichloro-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-(methylsulfonyl)phenyl)ethyl)-, rel-; ACETAMIDE, 2,2-DICHLORO-N-(.BETA.-HYDROXY-.ALPHA.-(HYDROXYMETHYL)-P-(METHYLSULFONYL)PHENETHYL)-, THREO-(+/-)-; Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-(methylsulfonyl)phenyl)ethyl)-, (R*,R*)-(+-)-; ACETAMIDE, 2,2-DICHLORO-N-(2-HYDROXY-1-(HYDROXYMETHYL)-2-(4-(METHYLSULFONYL)PHENYL)ETHYL)-, (R*,R*)-(+/-)-; TH8동의어